Cargando…

Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles

Bone marrow derived human mesenchymal stem cells (hMSCs) show promising potential in regeneration of defective tissue. Recently, gene silencing strategies using microRNAs (miR) emerged with the aim to expand the therapeutic potential of hMSCs. However, researchers are still searching for effective m...

Descripción completa

Detalles Bibliográficos
Autores principales: Schade, Anna, Delyagina, Evgenya, Scharfenberg, Dorothee, Skorska, Anna, Lux, Cornelia, David, Robert, Steinhoff, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709698/
https://www.ncbi.nlm.nih.gov/pubmed/23702843
http://dx.doi.org/10.3390/ijms140610710
_version_ 1782276782887534592
author Schade, Anna
Delyagina, Evgenya
Scharfenberg, Dorothee
Skorska, Anna
Lux, Cornelia
David, Robert
Steinhoff, Gustav
author_facet Schade, Anna
Delyagina, Evgenya
Scharfenberg, Dorothee
Skorska, Anna
Lux, Cornelia
David, Robert
Steinhoff, Gustav
author_sort Schade, Anna
collection PubMed
description Bone marrow derived human mesenchymal stem cells (hMSCs) show promising potential in regeneration of defective tissue. Recently, gene silencing strategies using microRNAs (miR) emerged with the aim to expand the therapeutic potential of hMSCs. However, researchers are still searching for effective miR delivery methods for clinical applications. Therefore, we aimed to develop a technique to efficiently deliver miR into hMSCs with the help of a magnetic non-viral vector based on cationic polymer polyethylenimine (PEI) bound to iron oxide magnetic nanoparticles (MNP). We tested different magnetic complex compositions and determined uptake efficiency and cytotoxicity by flow cytometry. Additionally, we monitored the release, processing and functionality of delivered miR-335 with confocal laser scanning microscopy, real-time PCR and live cell imaging, respectively. On this basis, we established parameters for construction of magnetic non-viral vectors with optimized uptake efficiency (~75%) and moderate cytotoxicity in hMSCs. Furthermore, we observed a better transfection performance of magnetic complexes compared to PEI complexes 72 h after transfection. We conclude that MNP-mediated transfection provides a long term effect beneficial for successful genetic modification of stem cells. Hence, our findings may become of great importance for future in vivo applications.
format Online
Article
Text
id pubmed-3709698
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-37096982013-07-12 Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles Schade, Anna Delyagina, Evgenya Scharfenberg, Dorothee Skorska, Anna Lux, Cornelia David, Robert Steinhoff, Gustav Int J Mol Sci Article Bone marrow derived human mesenchymal stem cells (hMSCs) show promising potential in regeneration of defective tissue. Recently, gene silencing strategies using microRNAs (miR) emerged with the aim to expand the therapeutic potential of hMSCs. However, researchers are still searching for effective miR delivery methods for clinical applications. Therefore, we aimed to develop a technique to efficiently deliver miR into hMSCs with the help of a magnetic non-viral vector based on cationic polymer polyethylenimine (PEI) bound to iron oxide magnetic nanoparticles (MNP). We tested different magnetic complex compositions and determined uptake efficiency and cytotoxicity by flow cytometry. Additionally, we monitored the release, processing and functionality of delivered miR-335 with confocal laser scanning microscopy, real-time PCR and live cell imaging, respectively. On this basis, we established parameters for construction of magnetic non-viral vectors with optimized uptake efficiency (~75%) and moderate cytotoxicity in hMSCs. Furthermore, we observed a better transfection performance of magnetic complexes compared to PEI complexes 72 h after transfection. We conclude that MNP-mediated transfection provides a long term effect beneficial for successful genetic modification of stem cells. Hence, our findings may become of great importance for future in vivo applications. Molecular Diversity Preservation International (MDPI) 2013-05-23 /pmc/articles/PMC3709698/ /pubmed/23702843 http://dx.doi.org/10.3390/ijms140610710 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Schade, Anna
Delyagina, Evgenya
Scharfenberg, Dorothee
Skorska, Anna
Lux, Cornelia
David, Robert
Steinhoff, Gustav
Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title_full Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title_fullStr Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title_full_unstemmed Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title_short Innovative Strategy for MicroRNA Delivery in Human Mesenchymal Stem Cells via Magnetic Nanoparticles
title_sort innovative strategy for microrna delivery in human mesenchymal stem cells via magnetic nanoparticles
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709698/
https://www.ncbi.nlm.nih.gov/pubmed/23702843
http://dx.doi.org/10.3390/ijms140610710
work_keys_str_mv AT schadeanna innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT delyaginaevgenya innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT scharfenbergdorothee innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT skorskaanna innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT luxcornelia innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT davidrobert innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles
AT steinhoffgustav innovativestrategyformicrornadeliveryinhumanmesenchymalstemcellsviamagneticnanoparticles